Microdose Psychedelic Insights, a cutting-edge media company focused on promoting content, financial analysis, and engaging events designed to drive the psychedelics industry into the forefront of modern medicine, announced that it will be hosting the Molecular Masterclass: LSD Conference next week. Microdose is hosting the event, scheduled for Feb. 17, 2022, in partnership with MindBio Therapeutics. The all-virtual conference is designed to offer a scientific deep dive into the dynamic field of LSD microdosing exploring the potential of LSD at the intersection of drug development and safety, clinical care and applications, law and regulation, business and markets, science and research, and history and culture. Presentations during the one-day event include “The History of That ‘Curious Molecule’” by Peter Van der Heyden, chief scientific officer at Psygen Industries, and William Leonard Pickard, former research associate in neurobiology at Harvard Medical School. Event participants can watch the presentation live and even participate in a question-and-answer session afterward. Other discussions include “The Therapeutic Use of LSD in Psychiatry,” “Posology and Tolerance to Regression,” “Safety and Efficacy of Lysergic Acid Diethylamide (LSD)-Assisted Psychotherapy,” “LSD Microdosing,” “Effect of Lysergic Acid Diethylamide (LSD) on Learning” and “The Effects of LSD on Creativity.” The event agenda also offers networking opportunities in group settings and one-on-one meetings. MindBio Therapeutics is a clinical-stage, drug-development company researching the medicinal use of psychedelic medicines to treat a range of debilitating mental health conditions.
To attend the event, visit https://ibn.fm/wxmBc
To view the full press release, visit https://ibn.fm/JfsC8
About Microdose Psychedelic Insights
Microdose Psychedelic Insights is a guide to the psychedelic medicine industry. With a vision to shift the world’s perception of psychedelic medicine, the company distribute and create the most compelling content, financial analysis, engaging events, and ground-breaking education to drive the psychedelics industry to the forefront of modern medicine. For more information about the company, visit www.Microdose.buzz.
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
For more information, please visit https://www.investorwire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]
InvestorWire is part of the InvestorBrandNetwork.